News Center - Luye Life Sciences

News Center

Luye Pharma Receives Clinical Trial Approval in Europe for Its Innovative Formulation Pali...

2023-02-24 MORE>
FDA Approves Luye Pharma’s Rykindo® for the Treatment of Schizophrenia and Bipolar 1 Diso...

2023-01-16 MORE>
Luye Pharma’s Innovative Anti-Cancer Therapy Lurbinectedin to Benefit “Named Patients” ...

2023-01-09 MORE>
Boan Biotech’s First Investigational ADC, BA1301 for Injection, Approved for Clinical Tri...

2023-01-09 MORE>
Boan Biotech Officially Listed on the Main Board of SEHK Accelerating to Become a Leading ...

2023-01-03 MORE>
Luye Pharma’s Innovative Formulation LY03010 Meets Endpoints in Pivotal U.S. Study

2022-11-22 MORE>

共150项 / 25页首页上一页 8 9 10 11 12 下一页尾页

鲁ICP备05023892号-5 LUYE All Rights Reserved Privacy policy Terms of use

TOP